Increased ACE activity is caused by AngII and functional polymorphisms in the ACE gene, which increases vulnerability to asthma, pulmonary hypertension, and chronic obstructive pulmonary disease (COPD). This evidence concerns the gene ACE and pulmonary arterial hypertension.